Category:Policy

From P2P Foundation
Revision as of 07:58, 22 February 2007 by Mbauwens (talk | contribs)
Jump to navigation Jump to search

This new category, created in June 2006, will focus on proposals to promote the P2P, Open/Free, and Commons-related agenda, in the existing political and institutional systems.

The P2P Foundation supports the emerging Coalition of the Commons

It will also include records on activist campaigns.


Introduction

Charles Leadbeater on Three Key Policy Reforms for Mass-based Innovation

Free Software for the Whole World, by Hipatia.

Capabilities in the information age. Philippe Aigrain


In French

Philippe Aigrain on a new policy for the information age

Region-specific

Europe

List of European Policy Consultants

Study on the Economic impact of open source software on innovation and the competitiveness of the Information and Communication Technologies (ICT) sector in the EU

The Open Society Institute on User Rights, Copyright and DRM in the EU


South

Salvador Declaration of Open Access for Developing Countries

Open Access for Developing Countries


Other Languages

L’économie de l’immatériel pour revitaliser la croissance française

"Dirigé par Maurice Lévy, le patron de Publicis, et Jean-Pierre Jouyet, chef du service de l’Inspection générale des finances, sur la base des travaux d’une commission rassemblant une vingtaine d’experts (parmi lesquels le président de la Fing, Philippe Lemoine), le rapport “L’économie de l’immatériel - La croissance de demain” (.pdf) dresse le constat de l’évolution de l’économie de l’immatériel pour revitaliser la croissance française." (http://www.internetactu.net/?p=6700)


Citations

Josef Stiglitz, on why drug patents are costing lives:

"Knowledge is like a candle, when one candle lights another it does not diminish its light.' In medicine, patents cost lives. The US patent for turmeric didn't stimulate research, and restricted access by the Indian poor who actually discovered it hundreds of years ago. 'These rights were intended to reduce access to generic medicines and they succeeded.' Billions of people, who live on $2-3 a day, could no longer afford the drugs they needed. Drug companies spend more on advertising and marketing than on research. A few scientists beat the human genome project and patented breast cancer genes; so now the cost of testing women for breast cancer is 'enormous." (http://www.bmj.com/cgi/content/full/333/7582/1279)

Pages in category "Policy"

The following 200 pages are in this category, out of 2,092 total.

(previous page) (next page)

A

B

C

(previous page) (next page)